Faculty profile

Yingying Su

Back to faculty

Lecturer (Adjunct)Pathology & Molecular MedicineMcMaster University

Yingying Su

Lecturer (Adjunct)

Pathology & Molecular Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2026

Email ORCID

Supervision signals

Adjunct, part-time and visiting faculty usually co-supervise alongside a core faculty member.
No graduate courses on record.
9 publications in the last five years, latest in 2026.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

suy36@mcmaster.ca

Research

Research areas, by share of publications

Cancer Immunotherapy and BiomarkersMedicine

Research areas are derived from OpenAlex topics of their publications.

10 publications.

PCSK9 promotes prostate cancer via facilitating intratumoral cholesterol accumulation and enhancing immunosuppressive tumor microenvironment

Gu Y, Wei F, Dong Y, Lin X, Su Y, Wood G, Seidah NG, Bonert M, Werstuck G, Aziz T

Journal of Advanced Research20263 citations

DOI: 10.1016/j.jare.2026.04.020

The Sig27 multigene stratifies breast cancer fatality risk via reflecting tumor-associated immune suppressive features

Su Y, Dong Y, Zhang T, Tang D

Translational Oncology2026First author

DOI: 10.1016/j.tranon.2026.102820

CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion

Dong Y, Su Y, Tang D

Biomolecules2026

DOI: 10.3390/biom16060923

A novel multigene panel (Sig27) robustly predicts poor prognosis of renal cell carcinoma via high-level associations with immunosuppressive features

Dong Y, Shayegan B, Su Y, Neira SV, Tang D

BJC Reports20256 citations

DOI: 10.1038/s44276-025-00128-3

IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms

Mei W, Dong Y, Gu Y, Kapoor A, Lin X, Su Y, Neira SV, Tang D

Journal of Advanced Research202312 citations

DOI: 10.1016/j.jare.2023.01.015

Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3

Lin X, Dong Y, Gu Y, Kapoor A, Peng J, Su Y, Wei F, Wang Y, Yang C, Gill A

Cancers202312 citationsOpen Access

DOI: 10.3390/cancers15123203 PMID: W4381462903

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors

Lin X, Dong Y, Gu Y, Wei F, Peng J, Su Y, Wang Y, Yang C, Neira SV, Kapoor A

Cancers20238 citationsOpen Access

DOI: 10.3390/cancers15194818 PMID: W4387259273

HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation

Wei F, Gu Y, He L, Kapoor A, Lin X, Dong Y, Su Y, Neira SV, Tang D

Metabolism: Clinical and Experimental20237 citations

DOI: 10.1016/j.metabol.2023.155631

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels

Lin X, Gu Y, Su Y, Dong Y, Major P, Kapoor A, Tang D

Cancers20226 citations

DOI: 10.3390/cancers14112805

Suppression of the dynamic interaction of estrogen receptor with chromatin is critical for therapeutic ligands to repress ER-mediated transcription activities

Chow MJ, Peng J, Su Y, Tang D

2020

DOI: 10.21037/biotarget.2020.01.01

Frequent collaborators

Co-authors at McMaster University. Thicker lines mean more shared papers.Explore the network

Michael Bonert

Pathology & Molecular Medicine

1 shared papers, latest 2026

Tariq Aziz

Pathology & Molecular Medicine

1 shared papers, latest 2026